178 related articles for article (PubMed ID: 11159685)
1. Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells.
Wickenden AD; Zou A; Wagoner PK; Jegla T
Br J Pharmacol; 2001 Jan; 132(2):381-4. PubMed ID: 11159685
[TBL] [Abstract][Full Text] [Related]
2. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
Wickenden AD; Yu W; Zou A; Jegla T; Wagoner PK
Mol Pharmacol; 2000 Sep; 58(3):591-600. PubMed ID: 10953053
[TBL] [Abstract][Full Text] [Related]
3. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
Main MJ; Cryan JE; Dupere JR; Cox B; Clare JJ; Burbidge SA
Mol Pharmacol; 2000 Aug; 58(2):253-62. PubMed ID: 10908292
[TBL] [Abstract][Full Text] [Related]
4. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
Tatulian L; Delmas P; Abogadie FC; Brown DA
J Neurosci; 2001 Aug; 21(15):5535-45. PubMed ID: 11466425
[TBL] [Abstract][Full Text] [Related]
5. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
Peretz A; Degani N; Nachman R; Uziyel Y; Gibor G; Shabat D; Attali B
Mol Pharmacol; 2005 Apr; 67(4):1053-66. PubMed ID: 15598972
[TBL] [Abstract][Full Text] [Related]
6. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC
Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837
[TBL] [Abstract][Full Text] [Related]
7. Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine.
Punke MA; Friederich P
Anesthesiology; 2004 Aug; 101(2):430-8. PubMed ID: 15277926
[TBL] [Abstract][Full Text] [Related]
8. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells.
Tatulian L; Brown DA
J Physiol; 2003 May; 549(Pt 1):57-63. PubMed ID: 12702739
[TBL] [Abstract][Full Text] [Related]
9. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.
Rundfeldt C; Netzer R
Neurosci Lett; 2000 Mar; 282(1-2):73-6. PubMed ID: 10713399
[TBL] [Abstract][Full Text] [Related]
10. Activation of KCNQ5 channels stably expressed in HEK293 cells by BMS-204352.
Dupuis DS; Schrøder RL; Jespersen T; Christensen JK; Christophersen P; Jensen BS; Olesen SP
Eur J Pharmacol; 2002 Feb; 437(3):129-37. PubMed ID: 11890900
[TBL] [Abstract][Full Text] [Related]
11. KCNQ4 channel activation by BMS-204352 and retigabine.
Schrøder RL; Jespersen T; Christophersen P; Strøbaek D; Jensen BS; Olesen SP
Neuropharmacology; 2001 Jun; 40(7):888-98. PubMed ID: 11378159
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR
J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569
[TBL] [Abstract][Full Text] [Related]
13. Molecular correlates of the M-current in cultured rat hippocampal neurons.
Shah M; Mistry M; Marsh SJ; Brown DA; Delmas P
J Physiol; 2002 Oct; 544(Pt 1):29-37. PubMed ID: 12356878
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
15. An osmosensitive voltage-gated K+ current in rat supraoptic neurons.
Zhang W; Wang D; Liu XH; Kosala WR; Rajapaksha JS; Fisher TE
Eur J Neurosci; 2009 Jun; 29(12):2335-46. PubMed ID: 19490083
[TBL] [Abstract][Full Text] [Related]
16. Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium.
Hadley JK; Passmore GM; Tatulian L; Al-Qatari M; Ye F; Wickenden AD; Brown DA
J Neurosci; 2003 Jun; 23(12):5012-9. PubMed ID: 12832524
[TBL] [Abstract][Full Text] [Related]
17. Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.
Li Y; Gamper N; Shapiro MS
J Neurosci; 2004 Jun; 24(22):5079-90. PubMed ID: 15175377
[TBL] [Abstract][Full Text] [Related]
18. Modulation of ERG channels by XE991.
Elmedyb P; Calloe K; Schmitt N; Hansen RS; Grunnet M; Olesen SP
Basic Clin Pharmacol Toxicol; 2007 May; 100(5):316-22. PubMed ID: 17448117
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity.
Lerche C; Scherer CR; Seebohm G; Derst C; Wei AD; Busch AE; Steinmeyer K
J Biol Chem; 2000 Jul; 275(29):22395-400. PubMed ID: 10787416
[TBL] [Abstract][Full Text] [Related]
20. The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation.
Dost R; Rostock A; Rundfeldt C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):382-90. PubMed ID: 15007538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
